Application of Clinical Trial Simulation to Compare Proof-of-Concept Study Designs for Drugs with a Slow Onset of Effect; An Example in Alzheimer's Disease

被引：0
|
作者：
Peter Lockwood
Wayne Ewy
David Hermann
Nick Holford
机构：
[1] Pfizer Global Research and Development,Department of Pharmacology and Clinical Pharmacology, School of Medicine
[2] deCODE genetics,undefined
[3] University of Auckland,undefined
来源：
Pharmaceutical Research | 2006年 / 23卷
关键词：
Alzheimer's disease; clinical trial simulation; pharmacokinetic pharmacodynamic model; trial design;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; an example in Alzheimer's disease
    Lockwood, Peter
    Ewy, Wayne
    Hermann, David
    Holford, Nick
    PHARMACEUTICAL RESEARCH, 2006, 23 (09) : 2050 - 2059
  • [2] Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study
    Danni Li
    Fangying Huang
    Yingchun Zhao
    Peter W. Villata
    Timothy J. Griffin
    Lin Zhang
    Ling Li
    Fang Yu
    Clinical Proteomics, 2018, 15
  • [3] Plasma lipoproteome in Alzheimer's disease: a proof-of-concept study
    Li, Danni
    Huang, Fangying
    Zhao, Yingchun
    Villata, Peter W.
    Griffin, Timothy J.
    Zhang, Lin
    Li, Ling
    Yu, Fang
    CLINICAL PROTEOMICS, 2018, 15
  • [4] Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease
    Koronyo, Yosef
    Biggs, David
    Barron, Ernesto
    Boyer, David S.
    Pearlman, Joel A.
    Au, William J.
    Kile, Shawn J.
    Blanco, Austin
    Fuchs, Dieu-Trang
    Ashfaq, Adeel
    Frautschy, Sally
    Cole, Gregory M.
    Miller, Carol A.
    Hinton, David R.
    Verdooner, Steven R.
    Black, Keith L.
    Koronyo-Hamaoui, Maya
    JCI INSIGHT, 2017, 2 (16)
  • [5] Elevated Aβ aggregates in feces from Alzheimer's disease patients: a proof-of-concept study
    Pils, Marlene
    Dybala, Alexandra
    Schaffrath, Anja
    Rehn, Fabian
    Kutzsche, Janine
    Bloemeke, Lara
    Tusche, Markus
    Oezduezenciler, Pelin
    Bujnicki, Tuyen
    Kraemer-Schulien, Victoria
    Gramespacher, Hannes
    Schmieschek, Maximilian H. T.
    Barbe, Michael T.
    Onur, Oezguer A.
    Fink, Gereon R.
    Tamguney, Gultekin
    Bannach, Oliver
    Willbold, Dieter
    ALZHEIMERS RESEARCH & THERAPY, 2024, 16 (01)
  • [6] Combined Effect of tDCS and Motor or Cognitive Activity in Patients with Alzheimer's Disease: A Proof-of-Concept Pilot Study
    Fonte, Cristina
    Rotundo, Giorgia
    Varalta, Valentina
    Filosa, Angelica
    Muti, Ettore
    Barletta, Cosimo
    Evangelista, Elisa
    Venturelli, Massimo
    Picelli, Alessandro
    Smania, Nicola
    BRAIN SCIENCES, 2024, 14 (11)
  • [7] Preclinical Biomarkers of Alzheimer's Disease Neuropathology in Young Adults with Youth-Onset Diabetes (YDM)-A Proof-of-Concept Study
    Shapiro, Allison
    Coughlan, Christina
    Kim, Jeongchul
    Potter, Huntington
    Bjornstad, Petter
    Pauley, Meghan E.
    Rajic, Benjamin S.
    Truong, Jennifer
    Glueck, Deborah H.
    Harrall, Kylie K.
    Barcus, Richard A.
    Tan, Josh
    Bettcher, Brianne
    Thaker, Ashesh
    Walker, Keenan A.
    Liese, Angela D.
    Dabelea, Dana
    Whitlow, Christopher T.
    DIABETES, 2023, 72
  • [8] Functional imaging of hippocampal dysfunction among persons with Alzheimer's disease: a proof-of-concept study
    Arciniegas, David B.
    Tregellas, Jason R.
    Rojas, Donald C.
    Hewitt, Burlleen
    Anderson, C. Alan
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2010, 6 : 779 - 783
  • [9] Double-blind, placebo-controlled, proof-of-concept trial of bexarotene in moderate Alzheimer’s disease
    Jeffrey L. Cummings
    Kate Zhong
    Jefferson W. Kinney
    Chelcie Heaney
    Joanne Moll-Tudla
    Abhinay Joshi
    Michael Pontecorvo
    Michael Devous
    Anne Tang
    James Bena
    Alzheimer's Research & Therapy, 8
  • [10] Proof-of-concept Clinical Trial: Prevent Cognitive Decline in GBA-Associated Parkinson's Disease
    Brockmann, K.
    Corvol, J. C.
    DiFonzo, A.
    Durrleman, S.
    Gasser, T.
    Hu, M.
    Krueger, R.
    Liepelt-Scarfone, I.
    Matarazzo, M.
    Pilotto, A.
    Simuni, T.
    Svenningsson, P.
    Weintraub, D.
    Pagano, G.
    MOVEMENT DISORDERS, 2023, 38 : S14 - S14
12345